These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 37262315)
21. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Tamarat R; Silvestre JS; Kubis N; Benessiano J; Duriez M; deGasparo M; Henrion D; Levy BI Hypertension; 2002 Mar; 39(3):830-5. PubMed ID: 11897773 [TBL] [Abstract][Full Text] [Related]
22. Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: An experimental rat model. Bahadır A; Ceyhan A; Öz Gergin Ö; Yalçın B; Ülger M; Özyazgan TM; Yay A Anatol J Cardiol; 2018 Mar; 19(3):213-221. PubMed ID: 29521316 [TBL] [Abstract][Full Text] [Related]
23. Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat. Sung PH; Chai HT; Yang CC; Chiang JY; Chen CH; Chen YL; Yip HK Biomed Pharmacother; 2022 Apr; 148():112745. PubMed ID: 35202913 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms mediating the cardioprotective effect of carvedilol in cadmium induced cardiotoxicity. Role of eNOS and HO1/Nrf2 pathway. Refaie MMM; El-Hussieny M; Bayoumi AMA; Shehata S Environ Toxicol Pharmacol; 2019 Aug; 70():103198. PubMed ID: 31154273 [TBL] [Abstract][Full Text] [Related]
25. Sacubitril/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation. Tantisuwat L; Saengklub N; Boonpala P; Kumphune S; Panyasing Y; Kalandakanond-Thongsong S; Kijtawornrat A Sci Rep; 2023 Jul; 13(1):11472. PubMed ID: 37455281 [TBL] [Abstract][Full Text] [Related]
26. Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats. Li Q; Fang Y; Peng DW; Li LA; Deng CY; Yang H; Kuang SJ; Li QQ; Zhang MZ; Zeng P; Zhang QH; Liu Y; Deng H; Wei W; Xue YM; Wu SL; Rao F Eur J Pharmacol; 2023 Aug; 952():175754. PubMed ID: 37182595 [TBL] [Abstract][Full Text] [Related]
27. Cardioprotective effect of green tea extract and vitamin E on Cisplatin-induced cardiotoxicity in mice: Toxicological, histological and immunohistochemical studies. Ibrahim MA; Bakhaat GA; Tammam HG; Mohamed RM; El-Naggar SA Biomed Pharmacother; 2019 May; 113():108731. PubMed ID: 30851549 [TBL] [Abstract][Full Text] [Related]
28. Genotoxicity, nitric oxide level modulation and cardio-protective potential of Kalanchoe Integra Var. Crenata (Andr.) Cuf Leaves in murine models. Asiedu-Gyekye IJ; Arhin E; Arthur SA; N'guessan BB; Amponsah SK J Ethnopharmacol; 2022 Jan; 283():114640. PubMed ID: 34606947 [TBL] [Abstract][Full Text] [Related]
29. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways. El-Ela SRA; Zaghloul RA; Eissa LA Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809 [TBL] [Abstract][Full Text] [Related]
30. Comparative Efficacy of Levosimendan, Ramipril, and Sacubitril/ Valsartan in Isoproterenol-induced Experimental Heart Failure: A Hemodynamic and Molecular Approach. Akhtar MS; Hassan Q; Afzal O; Altamimi A; Hassan MZ; Sharma AK; Mohammad AAS; Tabassum F Curr Mol Pharmacol; 2023; 16(6):629-639. PubMed ID: 36121084 [TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effect of canagliflozin against cisplatin-induced cerebral cortex injury is mediated by regulation of HO-1/PPAR-γ, SIRT1/FOXO-3, JNK/AP-1, TLR4/iNOS, and Ang II/Ang 1-7 signals. Hassanein EHM; Saleh FM; Ali FEM; Rashwan EK; Atwa AM; Abd El-Ghafar OAM Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):304-316. PubMed ID: 36326099 [TBL] [Abstract][Full Text] [Related]
32. Fertility protective effect of taxifolin in cisplatin-induced ovarian damage. Ozyurt R; Celik N; Suleyman Z; Cagiran F; Kali Z; Gurkan N; Altindag F; Bulut S; Sarigul C; Dinc K; Suleyman H Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7195-7203. PubMed ID: 36263529 [TBL] [Abstract][Full Text] [Related]
33. Sitagliptin prevents isoproterenol-induced myocardial infarction in rats by modulating nitric oxide synthase enzymes. Ibrahim MA; Geddawy A; Abdel-Wahab S Eur J Pharmacol; 2018 Jun; 829():63-69. PubMed ID: 29655978 [TBL] [Abstract][Full Text] [Related]
34. Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts. Li X; Braza J; Mende U; Choudhary G; Zhang P Sci Rep; 2021 Aug; 11(1):16542. PubMed ID: 34400686 [TBL] [Abstract][Full Text] [Related]
36. The protective effect of thiamine pyrophosphate, but not thiamine, against cardiotoxicity induced with cisplatin in rats. Coskun R; Turan MI; Turan IS; Gulapoglu M Drug Chem Toxicol; 2014 Jul; 37(3):290-4. PubMed ID: 24215635 [TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase inhibitor, Vinpocetine, guards against doxorubicin induced cardiotoxicity Refaie MMM; El-Hussieny M; Abdel-Hakeem EA; Fawzy MA; Mahmoud Abd El Rahman ES; Shehata S Hum Exp Toxicol; 2022; 41():9603271221136209. PubMed ID: 36270296 [TBL] [Abstract][Full Text] [Related]
38. Angiotensin Receptor Blocker and Neprilysin Inhibitor Suppresses Cardiac Dysfunction by Accelerating Myocardial Angiogenesis in Apolipoprotein E-Knockout Mice Fed a High-Fat Diet. Suematsu Y; Tashiro K; Morita H; Ideishi A; Kuwano T; Miura SI J Renin Angiotensin Aldosterone Syst; 2021; 2021():9916789. PubMed ID: 34394711 [TBL] [Abstract][Full Text] [Related]
39. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat. Habibi J; Aroor AR; Das NA; Manrique-Acevedo CM; Johnson MS; Hayden MR; Nistala R; Wiedmeyer C; Chandrasekar B; DeMarco VG Cardiovasc Diabetol; 2019 Mar; 18(1):40. PubMed ID: 30909895 [TBL] [Abstract][Full Text] [Related]
40. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines. Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]